You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

Bulk Pharmaceutical API Sources for alprazolam


✉ Email this page to a colleague

« Back to Dashboard


Bulk Pharmaceutical API Sources for alprazolam

Vendor Vendor Homepage Vendor Sku API Url
Sigma-Aldrich ⤷  Start Trial A8800_SIGMA ⤷  Start Trial
Hangzhou APIChem Technology ⤷  Start Trial AC-18721 ⤷  Start Trial
AKos Consulting & Solutions ⤷  Start Trial AKOS005066050 ⤷  Start Trial
Vitas-M Laboratory ⤷  Start Trial STK590494 ⤷  Start Trial
>Vendor >Vendor Homepage >Vendor Sku >API Url

Bulk Active Pharmaceutical Ingredient Sources for Alprazolam

Last updated: February 19, 2026

Alprazolam, a benzodiazepine used for anxiety and panic disorders, is manufactured globally. Multiple suppliers provide bulk Active Pharmaceutical Ingredient (API) to pharmaceutical companies. The primary sources include both licensed manufacturers and contract manufacturing organizations (CMOs) operating in Asia, Europe, and North America.

Major API Manufacturers for Alprazolam

China

China dominates the supply of generic APIs, including alprazolam. The government promotes pharmaceutical excipients and APIs as part of its manufacturing export strategy.

Company Name Location Certification Production Capacity Notes
Zhejiang Huahong Pharmaceutical Zhejiang GLP, ISO 9001 Estimated 10-20 MT/year Established supplier; API quality standards vary
Hainan Suning Pharmaceutical Hainan GMP, GLP Estimated 5-15 MT/year Focus on generic APIs; exports globally
Taizhou Kangyuan Pharmaceutical Zhejiang GMP Not publicly disclosed Produces multiple benzodiazepines with bulk API

India

India hosts several pharmatech firms manufacturing alprazolam API, mostly for export markets. They adhere to WHO and local standards.

Company Name Location Certification Production Capacity Notes
Solara Active Pharma Sciences Mumbai WHO-GMP Estimated 15-25 MT/year Approved API manufacturer, supplies to global pharma
Aurobindo Pharma Hyderabad USDMF, EUGMP Estimated 25-50 MT/year Large-scale API producer, multiple benzodiazepines
Natco Pharma Hyderabad USDMF, GLP Estimated 10-20 MT/year Focus on generic APIs, consistent quality

Europe

European API suppliers serve regulated markets such as the US and EU. Most operations adhere to strict Good Manufacturing Practice (GMP) standards.

Company Name Location Certification Production Capacity Notes
Estrasen (Spain) Barcelona EMA, GMP Not publicly disclosed Supplies alprazolam API for EU markets
Rottapharm Italy EMA, GMP Not publicly disclosed Focus on high-purity benzodiazepine APIs

North America

North American sources primarily import alprazolam API from Asia. Few domestic API producers exist at scale due to regulatory restrictions.

Company Name Location Certification Production Capacity Notes
Patheon (Thermo Fisher) Canada/USA cGMP Limited (for custom synthesis) Mainly contract manufacturing; API sourced globally

Supply Chain Considerations

  • Regulatory Compliance: Suppliers must comply with US FDA, EMA, or WHO standards. Certificates such as GMP, GLP, and DMF or CEP are essential.

  • Quality Assurance: Variability exists; quality standards depend on supplier certifications. High-grade suppliers provide API with assay purity above 99.5% and low residual solvents.

  • Production Scalability: Capacity ranges from 5-50 MT annually per manufacturer. Large-scale suppliers can meet global demand but may have longer lead times.

  • Pricing Trends: API costs fluctuate based on ingredient complexity, regulatory compliance, and raw material availability, with prices typically ranging from $20 to $80 per kilogram.

Market Dynamics

The global alprazolam API market is marked by:

  • Diverse Supplier Base: China and India represent the primary sources, with Europe and North America playing roles in high-value markets.
  • Regulatory Risks: Changes in export policies, such as China's pharmaceutical export restrictions, and stricter US/EU regulatory oversight influence supply stability.
  • Quality Assurance: The market has an increasing demand for high-quality, API with documented compliance for regulated markets.

Key Takeaways

  • China and India are the primary sources of alprazolam API, with numerous suppliers offering a broad capacity range.
  • European suppliers focus on high-quality, regulated API, primarily serving EU and US markets.
  • North American sourcing relies heavily on imports from Asia, with limited domestic production.
  • Regulatory compliance, quality certifications, and capacity are critical factors in supplier selection.
  • Supply chain disruptions can impact prices and availability; buyers should verify supplier certifications and capacity.

FAQs

1. What certifications should I verify from alprazolam API suppliers?
GMP, GLP, cGMP, DMF, and CEP are essential for regulatory compliance. Verify certifications align with your target markets (US, EU, etc.).

2. How do pricing and quality relate for alprazolam API?
Higher-quality suppliers with strict certifications generally charge higher prices. Price ranges typically fall between $20–$80/kg, depending on purity and certifications.

3. Which regions are considered most reliable for alprazolam API?
Europe and North America are considered most reliable due to stricter regulatory oversight, but they have limited domestic production. Asia supplies dominate globally but require thorough quality checks.

4. Are there any recent regulatory restrictions affecting alprazolam API?
Regulatory agencies, notably the US FDA and EMA, enforce strict manufacturing standards. Export restrictions or scheduling changes can impact supply but are not currently restrictive in the main sourcing regions.

5. What factors influence the choice of a supplier?
Factors include compliance with regulatory standards, production capacity, API purity, certification documentation, and supply reliability.


References

  1. U.S. Food and Drug Administration. (2022). API manufacturing standards and regulations. FDA.gov.
  2. World Health Organization. (2021). Certificate of Suitability (CEP) for Active Pharmaceutical Ingredients. WHO.int.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.